Huntington's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You are willing and able to give your consent to take part in the study
- You can read and speak English
- You are willing to follow the study's procedures throughout the trial
For the control group (no Huntington's disease), you also need to:
- Have a specific genetic marker result of 26 or fewer CAG repeats (a genetic test result — confirm with trial site)
- Have a body mass index (BMI) between 18.5 and 24.9, which is considered a healthy weight range
For experimental group 1 (Huntington's disease with low body weight), you also need to:
- Have a BMI under 18.5 (underweight) or have lost a significant amount of weight without trying in the past 12 months
- Have a CAG repeat genetic test result between 40 and 59 (confirm with trial site)
- Have a confirmed diagnosis of Huntington's disease with very high certainty, based on a standard medical assessment tool called the UHDRS
- Be in an earlier to middle stage of Huntington's disease (Stage I, II, or III) based on how well you can carry out daily activities
For experimental group 2 (Huntington's disease with higher body weight), you also need to:
- Have a BMI over 25.0 (overweight or obese), or a BMI of 25.0 or below but with unexplained significant weight gain in the past 12 months
- Have a CAG repeat genetic test result between 40 and 59 (confirm with trial site)
- Have a confirmed diagnosis of Huntington's disease with very high certainty, based on the UHDRS assessment tool
- Be in an earlier to middle stage of Huntington's disease (Stage I, II, or III) based on daily functioning
Who may not be able to join:
- You have a CAG repeat result of 60 or higher, which is linked to a rare, early-onset form of Huntington's disease
- You have a CAG repeat result between 36 and 39, which is linked to a form of Huntington's disease with uncertain symptoms
- You are in a later stage of Huntington's disease (Stage 4 or beyond), which may involve needing a feeding tube
- You have taken certain medicines in the last 6 months, including antibiotics, antifungal or antiviral drugs, steroids, immune-suppressing drugs, chemotherapy, or high-dose probiotic supplements (over 100 million CFU) — everyday fermented foods like yogurt are not included in this restriction
- You have used antibiotic or steroid creams or ointments on your skin in the last 7 days
- You have an active or uncontrolled gut or digestive condition, such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, a persistent infection, or ongoing constipation or diarrhea
- You are currently unwell with an acute illness, with or without a fever, at the time samples are collected
- You have tested positive for HIV, hepatitis B, or hepatitis C
- You have a confirmed or suspected condition that weakens your immune system
- You have had major surgery on your digestive system (not including gallbladder or appendix removal)
- Your diet has changed significantly in the past month, such as cutting out or greatly increasing a major food group
- You have a recent history of regularly drinking excessive amounts of alcohol
- You have travelled outside of the United States in the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amber Southwell, PhD, University of Central Florida
Phone: 4072668742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To quantify relative abundance of entire gut microbiomes in people using Metagenomic analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.